GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) has received a tax demand of Rs 23.21 crore from the Income Tax Department following a scrutiny assessment for the Assessment Year 2023-24.
The order, dated March 23, 2026, was issued by the Centralized Processing Centre (CPC) and was received by the company on March 24, 2026.
According to the company’s regulatory disclosure, the demand arises post completion of the assessment proceedings. However, GSK Pharma has stated that it does not agree with the findings and is currently in the process of filing an appeal before the appropriate appellate authority.
Also Read: GSK Gets USFDA Nod for Liver Disease-Related Itching Drug Livnavo
The company clarified that, as of now, there is no impact on its financial statements or operations due to this development.
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source from: https://medicaldialogues.in/news/industry/pharma/gsk-pharma-slapped-rs-2321-crore-tax-demand-plans-appeal-167537
⏳ Offer ending soon ! 🚨 Last Chance Alert! 🚨 Don’t miss out on the GST Update Package (FY 2026–27) at a special discounted price!
🚀 EXCLUSIVE GST UPDATE PACKAGE — REAL-TIME UPDATES FOR FY 2026–27 By A2Z Academy | Led by CA (Adv) Bimal Jain
🔥 Special Price: ₹4,449/- only (Till March 31, 2026) (Original Price: ₹4,999 )
✨ Why Join This Package?
- ✔️ Real-Time GST & Other Key Updates
- ✔️ Original Copies of SC/HC Judgements, Circulars, Notifications & Press Releases
- ✔️ Weekly GST E-Newsletter (PDF)
- ✔️ GST Judgment Update Newsletters (PDF)
- ✔️ Simple GST Case Law Updates
- ✔️ Customs & DGFT Updates
- ✔️ Free GST Webinars & Programs …and much more — delivered directly to your Email & WhatsApp!
📌 Validity: April 01, 2026 – March 31, 2027
📌 No Login Required — Seamless updates throughout the financial year
📞 011-42427056
🌐 www.a2ztaxcorp.in
📧 info@a2ztaxcorp.com
Stay Updated: Know Every GST change with our comprehensive, real-time update package designed for professionals, corporates, and Tax practitioners.
